Picture of Entera Bio logo

ENTX — Entera Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Entera Bio Ltd expected to post a loss of 7 cents a share - Earnings Preview

* Entera Bio Ltd  ENTX.OQ   ENTX.O  is expected to show a
fall in
quarterly revenue when it reports  results on August 9
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Entera Bio Ltd is
for a
loss of 7 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$6​, above​ its last closing price of $0.80. ​​​

This summary was machine generated August 7 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Entera Bio

See all news